By Viviane Trojan
11 de October de 2023
Lexology GTDT – Pharma & Medical Device Regulation 2024
The chapter “Pharma & Medical Device Regulation,” authored by our partners Claudio Barbosa, Viviane Trojan and attorney at law Giovanna Mezher, has been published on the Lexology’s special guide, Getting The Deal Through.
The content covers a vast legislative material regarding the pharmaceutical and healthcare equipment sector in Brazil, delving into the regulatory framework, rules for clinical practice, marketing and amending authorizations, product recalls, advertising and promotion, off-label use and unlicensed products, as well as sale and supply regulations, along with updates and trends in the field.
On the website, you can find laws and regulations from countries around the globe in a democratized manner, available to everyone, with Kasznar Leonardos representing Brazil in this dissemination.
Read the full content here.
Last by Viviane Trojan
19 de August de 2026
Brazilian PTO Publishes 2027–2036 Strategic Plan: What It Means for Users of Brazil’s IP System
Brazil’s National Institute of Industrial Property (INPI) released its new Strategic Plan for 2027–2036 on August 14, 2026. The plan launches a … Brazilian PTO Publishes 2027–2036 Strategic Plan: What It Means for Users of Brazil’s IP System
5 de August de 2026
Bill No. 2,210/2022 Advances in the Senate and Expands the Debate on Brazil’s Patent System
We have been closely monitoring the progress of Bill No. 2,210/2022, which proposes significant amendments to the Brazilian Industrial Property Law, Law … Bill No. 2,210/2022 Advances in the Senate and Expands the Debate on Brazil’s Patent System
8 de July de 2026
SEP Patents: Respect for the principle of objective good faith in negotiations, the duty of procedural loyalty, and the burden of proof regarding FRAND elements
ABSTRACT: The increasing judicialization of disputes involving Standard Essential Patents (SEPs) has shifted the focus of legal debate beyond the mere assessment … SEP Patents: Respect for the principle of objective good faith in negotiations, the duty of procedural loyalty, and the burden of proof regarding FRAND elements